KH Neochem Co., Ltd. (TSE: 4189, President and CEO: Michio Takahashi, “KH Neochem”) will be exhibiting for the second consecutive year at the at the “BIO International Convention 2025*” held in Boston, Massachusetts, USA, from June 16-19, 2025.
KH Neochem will participate in the Japan Pavilion (booth No. 2265), organized by the Japan External Trade Organization (JETRO)**.
Bio international Convention is as known as one of the world biggest business networking events for biotechnology field. The event brings together pharmaceutical and biotech companies, as well as research institutions from around the world, with the aim of revitalizing the bio-health industry and promoting its global development.
In our booth, we will mainly present these contents:
・N-Glycan Reagents ”GlyMuch®” for Advanced Research
・N-Glycosylation Services for Drug Discovery
- For more details about the event, please visit “BIO International Convention 2025”
- About Glycans
KH Neochem, aiming to achieve our “VISION 2030***,” has designated “Environment,” “Healthcare,” and “Electronics” as strategic domains. “KH i-Lab,” a newly established research hub, has been dedicated to accelerating research and development and driving creation of new businesses by leveraging an open innovation strategy. In the healthcare domain, KH Neochem has focused on the potential of glycans, and has developed proprietary glycans and manufacturing technologies.
In living organisms, glycans are linked to proteins and lipids on cell surfaces and within cells. Due to modulating the function and stability of the binding substances, glycoproteins and glycolipids influence various biological events such as cell adhesion and differentiation. It has been known that many diseases and disorders are associated with glycan abnormalities. Along with nucleic acids and proteins, these glycans comprise “the third life chain” because of their involvement in various vital phenomena.
As the third life chain, glycans have been actively investigated in life science fields to elucidate vital biological processes and develop new drugs, but artificial synthesis of glycans is difficult because of the great diversity of glycan structures. Ensuring a stable and sufficient supply of glycans remains a major challenge, not only for academic research but also for industrial applications. KH Neochem has developed original glycan manufacturing technology to ensure a stable supply and is accelerating marketing efforts to explore partners for value creation through glycan applications.
■EVENT INFORMATION
| Event name | BIO International Convention 2025 |
| Organizer | Biotechnology Innovation Organization |
| Dater | June 16(MON)-19(THU) 2025 |
| Venue | Boston Convention & Exhibition Center 415 Summer Street Boston, MA 02210 https://convention.bio.org/bio-2025/venue |
| Booth No. | 2265 (Japan Pavilion) https://bio2025.mapyourshow.com/8_0/floorplan/ |
| Exhibit | ・N-Glycan Reagents for Advanced Research ・N-Glycosylation Services for Drug Discovery |
■About glycans
https://www.khneochem.co.jp/en/solution/glycan/
■GlyMuch™ glycans by KH Neochem
https://www.khneochem.co.jp/en/solution/glycan/library/
*「BIO International Convention 2025」
https://convention.bio.org/
**「Japan External Trade Organization (JETRO)」
https://www.jetro.go.jp/en/
*** 「VISION 2030」
https://ssl4.eir-parts.net/doc/4189/ir_material4/152214/00.pdf
250613_KH Neochem to Exhibit at BIO International Convention 2025
For inquiries regarding this matter, please contact:
・Corporate Communications and Investor Relations KH Neochem Co., Ltd.
kouhou@khneochem.co.jp
・KH i-Lab:KH Neochem innovation Laboratory
innovation@khneochem.co.jp